Principal Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31M | Buy |
97,971
+2,255
| +2% | +$531K | 0.02% | 739 |
|
|
2026
Q1 | $19.1M | Buy |
95,716
+1,886
| +2% | +$373K | 0.01% | 958 |
|
|
2025
Q4 | $17.7M | Sell |
93,830
-772
| -0.8% | -$148K | 0.01% | 969 |
|
|
2025
Q3 | $16.8M | Sell |
94,602
-7,210
| -7% | -$1.07M | 0.01% | 969 |
|
|
2025
Q2 | $11.6M | Sell |
101,812
-1,062
| -1% | -$114K | 0.01% | 1172 |
|
|
2025
Q1 | $10.8M | Buy |
102,874
+3,284
| +3% | +$371K | 0.01% | 1212 |
|
|
2024
Q4 | $10.7M | Buy |
99,590
+6,382
| +7% | +$721K | 0.01% | 1262 |
|
|
2024
Q3 | $9.33M | Buy |
93,208
+4,439
| +5% | +$447K | 0.01% | 1319 |
|
|
2024
Q2 | $7.48M | Sell |
88,769
-3,355
| -4% | -$267K | ﹤0.01% | 1407 |
|
|
2024
Q1 | $6.73M | Sell |
92,124
-686
| -0.7% | -$50.6K | ﹤0.01% | 1478 |
|
|
2023
Q4 | $6.63M | Sell |
92,810
-1,268
| -1% | -$74.8K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $5.64M | Sell |
94,078
-3,982
| -4% | -$262K | ﹤0.01% | 1491 |
|
|
2023
Q2 | $7.07M | Sell |
98,060
-3,610
| -4% | -$271K | ﹤0.01% | 1406 |
|
|
2023
Q1 | $7.48M | Sell |
101,670
-1,899
| -2% | -$135K | 0.01% | 1390 |
|
|
2022
Q4 | $6.92M | Sell |
103,569
-60,456
| -37% | -$3.93M | 0.01% | 1419 |
|
|
2022
Q3 | $8.81M | Sell |
164,025
-18,719
| -10% | -$1.1M | 0.01% | 1257 |
|
|
2022
Q2 | $10.2M | Sell |
182,744
-13,489
| -7% | -$765K | 0.01% | 1242 |
|
|
2022
Q1 | $13.8M | Sell |
196,233
-13,694
| -7% | -$994K | 0.01% | 1186 |
|
|
2021
Q4 | $20.2M | Sell |
209,927
-55,708
| -21% | -$5.15M | 0.01% | 942 |
|
|
2021
Q3 | $23.1M | Buy |
265,635
+89,629
| +51% | +$6.93M | 0.02% | 826 |
|
|
2021
Q2 | $14.4M | Buy |
176,006
+14,089
| +9% | +$1.17M | 0.01% | 1220 |
|
|
2021
Q1 | $15.4M | Buy |
161,917
+19,999
| +14% | +$1.89M | 0.01% | 1132 |
|
|
2020
Q4 | $8.8M | Sell |
141,918
-16,888
| -11% | -$963K | 0.01% | 1311 |
|
|
2020
Q3 | $9.44M | Buy |
158,806
+32,227
| +25% | +$2.2M | 0.01% | 1112 |
|
|
2020
Q2 | $8.83M | Buy |
126,579
+43,616
| +53% | +$2.77M | 0.01% | 1129 |
|
|
2020
Q1 | $3.76M | Sell |
82,963
-41,076
| -33% | -$2.33M | ﹤0.01% | 1398 |
|
|
2019
Q4 | $8.07M | Sell |
124,039
-5,459
| -4% | -$365K | 0.01% | 1354 |
|
|
2019
Q3 | $8.04M | Sell |
129,498
-6,484
| -5% | -$407K | 0.01% | 1323 |
|
|
2019
Q2 | $9.68M | Sell |
135,982
-10,289
| -7% | -$758K | 0.01% | 1240 |
|
|
2019
Q1 | $11.5M | Sell |
146,271
-4,804
| -3% | -$364K | 0.01% | 1152 |
|
|
2018
Q4 | $12.8M | Sell |
151,075
-151,334
| -50% | -$16.1M | 0.01% | 1012 |
|
|
2018
Q3 | $51.8M | Buy |
302,409
+8,861
| +3% | +$1.34M | 0.05% | 410 |
|
|
2018
Q2 | $37.9M | Buy |
293,548
+831
| +0.3% | +$92.7K | 0.03% | 486 |
|
|
2018
Q1 | $30.2M | Buy |
292,717
+8,473
| +3% | +$838K | 0.03% | 569 |
|
|
2017
Q4 | $24.3M | Buy |
284,244
+25,204
| +10% | +$2.18M | 0.02% | 692 |
|
|
2017
Q3 | $22M | Buy |
259,040
+19,879
| +8% | +$1.57M | 0.02% | 718 |
|
|
2017
Q2 | $18.1M | Sell |
239,161
-20,491
| -8% | -$1.43M | 0.02% | 827 |
|
|
2017
Q1 | $17.1M | Buy |
259,652
+8,044
| +3% | +$529K | 0.02% | 824 |
|
|
2016
Q4 | $15.9M | Buy |
251,608
+21,023
| +9% | +$1.33M | 0.02% | 847 |
|
|
2016
Q3 | $14.7M | Buy |
230,585
+11,271
| +5% | +$828K | 0.02% | 855 |
|
|
2016
Q2 | $16.3M | Buy |
219,314
+15,087
| +7% | +$1.12M | 0.02% | 741 |
|
|
2016
Q1 | $13.6M | Buy |
204,227
+7,900
| +4% | +$480K | 0.02% | 796 |
|
|
2015
Q4 | $13.3M | Buy |
196,327
+9,148
| +5% | +$565K | 0.02% | 772 |
|
|
2015
Q3 | $10M | Buy |
187,179
+7,571
| +4% | +$459K | 0.02% | 922 |
|
|
2015
Q2 | $11.3M | Sell |
179,608
-3,382
| -2% | -$185K | 0.02% | 915 |
|
|
2015
Q1 | $8.8M | Sell |
182,990
-61
| -0% | -$2.34K | 0.01% | 1063 |
|
|
2014
Q4 | $6.08M | Sell |
183,051
-6,242
| -3% | -$203K | 0.01% | 1283 |
|
|
2014
Q3 | $5.55M | Sell |
189,293
-19,865
| -9% | -$659K | 0.01% | 1290 |
|
|
2014
Q2 | $8.13M | Buy |
209,158
+8
| +0% | +$325 | 0.01% | 1073 |
|
|
2014
Q1 | $8.78M | Buy |
209,150
+9,310
| +5% | +$388K | 0.02% | 995 |
|
|
2013
Q4 | $6.56M | Buy |
199,840
+190,935
| +2,144% | +$6.22M | 0.01% | 1172 |
|
|
2013
Q3 | $240K | Sell |
8,905
-583
| -6% | -$16.4K | ﹤0.01% | 2041 |
|
|
2013
Q2 | $221K | Buy |
+9,488
| New | +$171K | ﹤0.01% | 2043 |
|
Other funds holding LGND
JT
CAM
Principal Financial Group's LGND Position: Q2 2026 in Review
Principal Financial Group increased its Ligand Pharmaceuticals (LGND) stake by 2.4% in Q2 2026, buying an estimated $531K and bringing the position to 97,971 shares worth $31M. The position accounts for 0.02% of the portfolio, ranked #739.
Principal Financial Group first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $51.8M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Principal Financial Group held 97,971 shares of Ligand Pharmaceuticals worth $31M as of Q2 2026.
- Principal Financial Group bought 2,255 Ligand Pharmaceuticals shares in Q2 2026, an estimated $531K.
- Ligand Pharmaceuticals made up 0.02% of Principal Financial Group's portfolio in Q2 2026, its #739 holding.
- Principal Financial Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's Ligand Pharmaceuticals position peaked at $51.8M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.